Ping An To Invest RMB 500 Million In Healthcare Industry
This article was originally published in PharmAsia News
Executive Summary
Ping An Trust & Investment, a subsidiary of Ping An Insurance (Group), and Guangzhou Zhongda Holding have jointly set up the Guangzhou Yikang clinic chain with a total investment of RMB 200-500 million ($29.3-73 million). This represents Ping An's first launch of medical institutions since it entered the healthcare industry. With funding of RMB 8 million, the first Yikang clinic took about one year to go into operation, including negotiations, approval, location set-up and recruitment. Ten more clinics will be opened in the Pearl River Delta this year. Yikang will engage Hong Kong-based Town Health International Holdings as its management consultant to introduce an advanced medical service model. (Click here for more - Chinese Language)
You may also be interested in...
Small Sterilization Companies Poised To Meet EtO Emissions Goals On Time
Small sterilizers told Medtech Insight that they were ready for the EPA’s controversial EtO emissions rule, while community advocates expressed concerns.
Day One Springs Into Commercial Action With Ojemda Approval
The company is targeting around 200 centers that treat the vast majority of the few thousand pediatric low-grade glioma patients who are candidates for the RAF-targeting drug.
At-Home Health Testing Demand Is High Post-Pandemic, But So Are Barriers To Development And Use
At the recent Precision Med-Tri Con conference, laboratory experts traded views on the expansion of at-home testing for disease diagnosis and personalized health insights. While strong consumer demand spells opportunity, there are significant concerns about the accuracy and reliability of home-testing platforms, misuse, accessibility, and lack of health literacy.